Sars-Cov-2 Spike Protein Lp.8.1
ATC — · 1 markets · 8 records
Sars-Cov-2 Spike Protein Lp.8.1
Forms
AU 8 records · 6 strengths
- 0.016 mginjectionCOMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 10 micrograms/0.3 mL suspension for injection vialCOMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial
- 0.225 mginjectionCOMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial
- 0.1 mg/mLinjectionSPIKEVAX LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
- 0.074 mginjectionCOMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 10 micrograms/0.3 mL suspension for injection multidose vial
- 0.042 mginjectionCOMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection prefilled glass syringe
Records without a stated strength · 1 COMIRNATY LP.8.1、SPIKEVAX LP.8.1
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.